About Amrita Therapeutics
Amrita Therapeutics was a Healthcare company based in Ahmedabad (India) by Tony Fred. It specializes in antibody production, therapeutic development, and diagnostic tools for labs and companies. It operates on a B2B model. Amrita Therapeutics has raised $572.93 thousand across 3 funding rounds from investors including Gujarat Venture Finance, Department of Biotechnology and Ananda Chakrabarty. Its chief executive, as recorded, is Tony Fred. The company is recorded as dissolved. Amrita Therapeutics offers products and services including Antibodies, Therapeutics, Diagnostic Tools, and Custom Services. Its focus areas include Biotechnology, Antibodies, Production and Therapeutics. Its legal entity in India is Amrita Therapeutics Limited (U24239GJ2008PLC053030).
Company details
Amrita Therapeutics focuses on manufacturing high-quality antibodies, developing biological substances, and creating diagnostic kits for use in laboratories, hospitals, and biotech sectors. They offer services like custom antibody development and protein production, supporting research and clinical applications. Based in Blackpool, United Kingdom, they work with universities, pharmaceutical companies, and public health agencies to enable better diagnostics and treatments through reliable products and innovative tools.
- Headquarters Ahmedabad, India
- Founders Tony Fred
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amritatherapeutics.com
- Legal Name Amrita Therapeutics Limited
- Date of Incorporation 25 Feb, 2008
- Jurisdiction Ahmedabad, Gujarat, India
- Total Equity Funding$572.93K (USD)
in 3 rounds
- Latest Funding Round$172.93K (USD), Seed
Feb 2015
- InvestorsGujarat Venture Finance
& 2 more
Associated legal entities of Amrita Therapeutics
Amrita Therapeutics operates through Amrita Therapeutics Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2018) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amrita Therapeutics Limited CIN U24239GJ2008PLC053030 | Strike Off | 25 Feb 2008 | Ahmedabad, Gujarat | 3 | View details |
Products & Services of Amrita Therapeutics
Amrita Therapeutics offers a comprehensive portfolio of products and services, including Antibodies, Therapeutics, Diagnostic Tools, and Custom Services.
Various antibodies for research and diagnostics applications
Developments targeting diseases through antibody-based treatments
Kits for detecting infections and diseases in labs or clinics
Tailored antibody and assay development for client needs
Funding Insights of Amrita Therapeutics
Amrita Therapeutics has successfully raised a total of $572.93K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $172.93 thousand completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $572,934
- Total Rounds 3
- Last Round Seed — $172,934
- First Round $400,000
(Jul 2008)
- Investors Count 3
All 3 funding rounds of Amrita Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | $172,934 | Seed | – | – | |
| Mar 2010 | Grant | – | – | ||
| Jul 2008 | $400,000 | Seed | – | Gujarat Venture Finance | – |
3 investors in total: 2 institutional and 1 angel.
Investors in Amrita Therapeutics
Amrita Therapeutics has secured backing from 3 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Gujarat Venture Finance, Department of Biotechnology and Ananda Chakrabarty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are made in Indian startups across multiple sectors. | 1990 | gvfl.com | Ahmedabad, India | |
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
AC Ananda Chakrabarty | unknown_48509223fe8b49e1b |
Investor details for Amrita Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Amrita Therapeutics Limited (Amrita Therapeutics)
Amrita Therapeutics Limited is the primary company behind Amrita Therapeutics. The board of Amrita Therapeutics Limited currently have 3 directors; the longest-serving is Susan Kling Finston, appointed in 2008. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Susan Kling Finston DIN 01814164 | Director | 25 Feb 2008 | 18 yrs 8 mo | Amrita Therapeutics Limited |
| Himanshu Chimanlal Vyas DIN 02016148 | Director | 12 Aug 2008 | 18 yrs 3 mo | Amrita Therapeutics Limited |
| Mihirkumar Arvind Joshi DIN 00823615 | Nominee Director | 31 Jul 2009 | 17 yrs 3 mo | Amrita Therapeutics Limited |
People of Amrita Therapeutics
1 people are tracked at Amrita Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Tony Fred | Founder, CEO | Leadership |
Complete people profiles for Amrita Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Amrita Therapeutics
2 dated milestones of Amrita Therapeutics across 7 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $400K.
- Funding Latest funding round, Seed, of $173K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amrita Therapeutics
Amrita Therapeutics is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Tony Fred is the CEO of Amrita Therapeutics, as recorded in our data. They have also founded this company.
Amrita Therapeutics is a funded company, having raised a total of $572.93K across 3 funding rounds to date. The company's 1st funding round was a Seed of $400K, raised on Jul 2008.
Amrita Therapeutics focuses on manufacturing high-quality antibodies, developing biological substances, and creating diagnostic kits for use in laboratories, hospitals, and biotech sectors. They offer services like custom antibody development and protein production, supporting research and clinical applications. Based in Blackpool, United Kingdom, they work with universities, pharmaceutical companies, and public health agencies to enable better diagnostics and treatments through reliable products and innovative tools.
Amrita Therapeutics offers Antibodies, Therapeutics, Diagnostic Tools, and Custom Services.
Amrita Therapeutics has 3 investors. Key investors include Gujarat Venture Finance, Department of Biotechnology, and Ananda Chakrabarty.
Amrita Therapeutics operates through Amrita Therapeutics Limited.
The legal entities of Amrita Therapeutics currently have 3 directors, including Himanshu Chimanlal Vyas, Susan Kling Finston, Mihirkumar Arvind Joshi.